Zobrazeno 1 - 6
of 6
pro vyhledávání: '"N P, Wolfe"'
Publikováno v:
Journal of Clinical Neuroscience. 85:27-35
Stroke is a leading cause of morbidity and mortality worldwide. Although the majority of strokes affect the elderly, the incidence of stroke in young patients is on the rise. Prompt recognition of stroke symptoms and time critical therapies play a ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08bee064086efb5e98105e96eba674e
https://doi.org/10.1016/j.jocn.2020.12.017
https://doi.org/10.1016/j.jocn.2020.12.017
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 36
Ocular flutter is a dramatic clinical sign that poses multiple diagnostic considerations. The case description outlines a well young male that presented with ocular flutter and truncal ataxia. The clinical syndrome was subsequently attributed to ente
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c078b8fba786ccf77940d3bb580fd98
https://pubmed.ncbi.nlm.nih.gov/27825610
https://pubmed.ncbi.nlm.nih.gov/27825610
Autor:
Michael P. Pender, N. P. Wolfe
Publikováno v:
Internal Medicine Journal. 32:554-563
Multiple sclerosis (MS) is an important cause of progressive neurological disability, typically commencing in early adulthood. There is a need for safe and effective therapy to prevent the progressive central nervous system (CNS) damage and resultant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2eb7da8ba28935685d2ac04f8b20b943
https://doi.org/10.1046/j.1445-5994.2002.00269.x
https://doi.org/10.1046/j.1445-5994.2002.00269.x
Autor:
N. P. Wolfe, Michael P. Pender, Michael F. Good, Peter A. Csurhes, Judith M. Greer, Kaye D. Hooper, Pamela A. McCombe
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 10(1)
We have previously shown that patients with primary progressive multiple sclerosis (MS) have significantly elevated plasma levels of antibody to GM3 ganglioside compared to patients with relapsing-remitting MS, healthy subjects and patients with othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1777f54684429f6b51360107dee82fa
https://pubmed.ncbi.nlm.nih.gov/12464524
https://pubmed.ncbi.nlm.nih.gov/12464524
Autor:
M P, Pender, N P, Wolfe
Publikováno v:
Internal medicine journal. 32(11)
Multiple sclerosis (MS) is an important cause of progressive neurological disability, typically commencing in early adulthood. There is a need for safe and effective therapy to prevent the progressive central nervous system (CNS) damage and resultant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd8d58375cb5779945f9e2f923d80894
https://pubmed.ncbi.nlm.nih.gov/12412939
https://pubmed.ncbi.nlm.nih.gov/12412939
Publikováno v:
Multiple Sclerosis Journal. 10:1-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f5bd5f191af6e4a7545b6d2757ff59a
https://doi.org/10.1191/1352458504ms1003ed
https://doi.org/10.1191/1352458504ms1003ed